{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:52:26Z","timestamp":1783720346501,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010793","name":"Pfizer Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10792-018-0820-7","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T04:18:05Z","timestamp":1515730685000},"page":"375-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan"],"prefix":"10.1007","volume":"39","author":[{"given":"Toyoaki","family":"Tsumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Suzumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshine","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Araie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"issue":"10","key":"820_CR1","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B et al (2002) Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120(10):1268\u20131279","journal-title":"Arch Ophthalmol"},{"key":"820_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2174\/1874364101004010007","volume":"4","author":"K Kashiwagi","year":"2010","unstructured":"Kashiwagi K (2010) Changes in trend of newly prescribed anti-glaucoma medications in recent 9\u00a0years in a Japanese local community. Open Ophthalmol J 4:7\u201311","journal-title":"Open Ophthalmol J"},{"issue":"2","key":"820_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ophtha.2008.09.004","volume":"116","author":"CO Okeke","year":"2009","unstructured":"Okeke CO, Quigley HA, Jampel HD et al (2009) Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology 116(2):191\u2013199","journal-title":"Ophthalmology"},{"key":"820_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2147\/OPTH.S49467","volume":"8","author":"JH Campbell","year":"2014","unstructured":"Campbell JH, Schwartz GF, LaBounty B et al (2014) Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions. Clin Ophthalmol 8:927\u2013935","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"820_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","volume":"140","author":"BL Nordstrom","year":"2005","unstructured":"Nordstrom BL, Friedman DS, Mozaffari E et al (2005) Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 140(4):598\u2013606","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"820_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10384-012-0188-6","volume":"57","author":"MH Park","year":"2013","unstructured":"Park MH, Kang KD, Moon J (2013) Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study. Jpn J Ophthalmol 57(1):47\u201356","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"820_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10384-013-0284-2","volume":"58","author":"K Kashiwagi","year":"2014","unstructured":"Kashiwagi K, Furuya T (2014) Persistence with topical glaucoma therapy among newly diagnosed Japanese patients. Jpn J Ophthalmol 58(1):68\u201374","journal-title":"Jpn J Ophthalmol"},{"key":"820_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/PPA.S23780","volume":"5","author":"G Reardon","year":"2011","unstructured":"Reardon G, Kotak S, Schwartz GF (2011) Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence 5:441\u2013463","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"820_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/eye.2011.269","volume":"26","author":"TA Gray","year":"2012","unstructured":"Gray TA, Fenerty C, Harper R et al (2012) Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trial. Eye (London) 26(3):407\u2013417","journal-title":"Eye (London)"},{"issue":"5","key":"820_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/archophthalmol.2010.345","volume":"129","author":"DT Quek","year":"2011","unstructured":"Quek DT, Ong GT, Perera SA et al (2011) Persistence of patients receiving topical glaucoma monotherapy in an Asian population. Arch Ophthalmol 129(5):643\u2013648","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"820_CR11","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/eye.2008.213","volume":"23","author":"CG Owen","year":"2009","unstructured":"Owen CG, Carey IM, de Wilde S et al (2009) Persistency with medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994\u20132005. Eye (London) 23(5):1098\u20131110","journal-title":"Eye (London)"},{"issue":"3","key":"820_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/IJG.0b013e3181815421","volume":"18","author":"F Djafari","year":"2009","unstructured":"Djafari F, Lesk MR, Harasymowycz PJ et al (2009) Determinants of adherence to glaucoma medical therapy in a long-term patient population. J Glaucoma 18(3):238\u2013243","journal-title":"J Glaucoma"},{"issue":"5","key":"820_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2105\/AJPH.83.5.711","volume":"83","author":"JH Gurwitz","year":"1993","unstructured":"Gurwitz JH, Glynn RJ, Monane M et al (1993) Treatment for glaucoma: adherence by the elderly. Am J Public Health 83(5):711\u2013716","journal-title":"Am J Public Health"},{"issue":"5","key":"820_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ophtha.2004.12.026","volume":"112","author":"AL Robin","year":"2005","unstructured":"Robin AL, Covert D (2005) Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology 112(5):863\u2013868","journal-title":"Ophthalmology"},{"issue":"4","key":"820_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ajo.2007.06.012","volume":"144","author":"AL Robin","year":"2007","unstructured":"Robin AL, Novack GD, Covert DW et al (2007) Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol 144(4):533\u2013540","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"820_CR16","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1185\/03007995.2011.613923","volume":"27","author":"F Aptel","year":"2011","unstructured":"Aptel F, Denis P (2011) Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin-timolol fixed combinations in primary open-angle glaucoma. Curr Med Res Opin 27(10):1949\u20131958","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"820_CR17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1517\/14656566.9.6.1059","volume":"9","author":"M Herceg","year":"2008","unstructured":"Herceg M, Noecker R (2008) Travoprost\/timolol fixed combination. Expert Opin Pharmacother 9(6):1059\u20131065","journal-title":"Expert Opin Pharmacother"},{"key":"820_CR18","first-page":"1","volume":"4","author":"EJ Higginbotham","year":"2010","unstructured":"Higginbotham EJ (2010) Considerations in glaucoma therapy: fixed combinations versus their component medications. Clin Ophthalmol 4:1\u20139","journal-title":"Clin Ophthalmol"},{"key":"820_CR19","volume-title":"Adherence to long-term therapies: evidence for action","author":"E Sabat\u00e9","year":"2003","unstructured":"Sabat\u00e9 E (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva"},{"key":"820_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2415-14-32","volume":"14","author":"H Cate","year":"2014","unstructured":"Cate H, Bhattacharya D, Clark A et al (2014) Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study). BMC Ophthalmol 14:32","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"820_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/02713683.2014.1002045","volume":"41","author":"LE Dreer","year":"2016","unstructured":"Dreer LE, Owsley C, Campbell L et al (2016) Feasibility, patient acceptability, and preliminary efficacy of a culturally informed, health promotion program to improve glaucoma medication adherence among African Americans: \u201cGlaucoma Management Optimism for African Americans Living with Glaucoma\u201d (GOAL). Curr Eye Res 41(1):50\u201358","journal-title":"Curr Eye Res"},{"issue":"5","key":"820_CR22","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1097\/IJG.0000000000000007","volume":"24","author":"SC Loon","year":"2015","unstructured":"Loon SC, Jin J, Jin Goh M (2015) The relationship between quality of life and adherence to medication in glaucoma patients in Singapore. J Glaucoma 24(5):e36\u2013e42","journal-title":"J Glaucoma"},{"key":"820_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2147\/PPA.S61505","volume":"8","author":"JA Rosdahl","year":"2014","unstructured":"Rosdahl JA, Swamy L, Stinnett S et al (2014) Patient education preferences in ophthalmic care. Patient Prefer Adherence 8:565\u2013574","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"820_CR24","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.2196\/jmir.2795","volume":"16","author":"K Kashiwagi","year":"2014","unstructured":"Kashiwagi K, Tsukahara S (2014) Impact of patient access to Internet health records on glaucoma medication: randomized controlled trial. J Med Internet Res 16(1):e15","journal-title":"J Med Internet Res"},{"issue":"6","key":"820_CR25","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.ophtha.2009.01.021","volume":"116","author":"DS Friedman","year":"2009","unstructured":"Friedman DS, Okeke CO, Jampel HD et al (2009) Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology 116(6):1097\u20131105","journal-title":"Ophthalmology"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-018-0820-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0820-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0820-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T14:16:00Z","timestamp":1572012960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-018-0820-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1007\/s10792-018-0820-7","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,12]]},"assertion":[{"value":"6 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no proprietary or commercial interests in any materials discussed in this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}